MedPath

石家庄鹏海制药股份有限公司

Ownership
-
Established
2006-12-04
Employees
-
Market Cap
-
Website
http://www.penghaizhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

32

NMPA:32

Drug Approvals

Glucose lnjection

Product Name
葡萄糖注射液
Approval Number
国药准字H20153316
Approval Date
Dec 7, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20153312
Approval Date
Dec 7, 2020
NMPA

Glucose lnjection

Product Name
葡萄糖注射液
Approval Number
国药准字H20153314
Approval Date
Dec 7, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20153313
Approval Date
Dec 7, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20153310
Approval Date
Dec 7, 2020
NMPA

Glucose lnjection

Product Name
葡萄糖注射液
Approval Number
国药准字H20153315
Approval Date
Dec 7, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20153311
Approval Date
Dec 7, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20103478
Approval Date
Sep 20, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20093166
Approval Date
Sep 20, 2020
NMPA

Dextran 40 and Glucose lnjection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H13022064
Approval Date
Sep 7, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.